Kalei Ventures

Kalei Ventures is a European early-stage venture fund focused on digital health, with a thesis built around backing software and tech-enabled care companies addressing meaningful clinical and access problems across European markets. The fund writes initial checks of roughly $500K to $3M at seed and Series A, can lead small rounds, and reserves capital for follow-on. Healthcare exposure is total and concentrated in digital health software, care delivery, and selectively diagnostics. AI focus is welcome where it sits inside a defensible commercial healthcare business with a clear European buyer. Founders best suited are European-headquartered seed and Series A digital health CEOs with multi-country expansion plans across the EU and UK, who want a healthcare-native lead with relationships to European payers, providers, and follow-on investors. Founders who do not fit include US-only digital health teams, therapeutics, devices, and consumer wellness without a clinical buyer. Geographic preference is Europe, with selective exposure to companies that target European markets from abroad. The entry path is warm introduction through a European digital health operator, a portfolio CEO, or a co-investor at funds like Heal Capital, Karista, or LSP. LinkedIn outreach to a partner with a focused European market summary and traction metrics is a reasonable secondary option. Expect commercial diligence specific to European reimbursement and regulatory environments, and a partner that values multi-country expansion strategy and clinical evidence generation.